Zentalis Pharmaceuticals, Inc. (ZNTL) Operating cash flow 2019–2025
Zentalis Pharmaceuticals, Inc. (ZNTL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$125.2MFY2025 · since FY2019: -$39.1M → -$125.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$125.2M | +26.7% |
| FY2024 | -$170.9M | +17.8% |
| FY2023 | -$207.8M | -26.9% |
| FY2022 | -$163.8M | -6.3% |
| FY2021 | -$154.1M | -77.5% |
| FY2020 | -$86.8M | -121.8% |
| FY2019 | -$39.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ZNTL financial trends
ZNTL RevenueZNTL Net incomeZNTL Net marginZNTL Gross profitZNTL Gross marginZNTL Operating incomeZNTL Operating marginZNTL Free cash flowZNTL Capital expendituresZNTL Return on equityZNTL Stock buybacksZNTL Dividends paidZNTL Total assetsZNTL Total liabilitiesZNTL Shareholders’ equityZNTL overview →